Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Venetoclax in Combination With R-ICE (V+RICE) Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT03064867 is registered in ClinicalTrials.gov with Molly Gallogly as lead sponsor.

NCT NCT03064867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03064867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Venetoclax in Combination With R-ICE (V+RICE) Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Lead sponsor
Molly Gallogly
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
June 26, 2017
Completion date
August 12, 2023
Enrollment
65 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell-lymphoma